| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.23 | 6e-06 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.21 | 9e-05 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.18 | 0.0009 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.18 | 0.001 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.17 | 9e-06 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.17 | 6e-06 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.16 | 3e-06 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.16 | 0.004 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.15 | 0.003 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.15 | 0.01 |